Skip to main content

Department of Pharmacology

Yohn named Postdoc of the Year at annual symposium; Sappington named Mentor of the Year

Apr. 22, 2019—Postdoctoral scholars Samantha Yohn and Anneke Sanders and ophthalmology professor Rebecca Sappington were honored by the Graduate School at the 13th Annual Vanderbilt Postdoctoral Association Symposium on April 9.

Read more


The arrestin-GPCR connection

Apr. 12, 2019—Vsevolod Gurevich and colleagues have discovered new insights into arrestin proteins, which turn off a cell's environmental message "inbox."

Read more


Reprogramming cells for kidney repair

Mar. 14, 2019—Lauren Woodard and Matthew Wilson have discovered a way to reprogram adult human kidney cells into cells similar to those that form during embryonic development, which could lead to new kidney disease treatments.

Read more


New way to stimulate learning?

Mar. 14, 2019—Stimulating the vagus nerve triggers certain epigenetic changes involving learning and memory.

Read more


Vanderbilt scientists report new modeling of brain signaling

Mar. 7, 2019—Heidi Hamm and colleagues have reported the first animal model of a "shut-off valve" for neurotransmitter and hormone release through SNARE complex-mediated membrane fusion.

Read more


Gene identified that increases risk of antibiotic reaction

Feb. 28, 2019—Researchers at Vanderbilt University Medical Center and colleagues have identified a gene that increases the risk for a severe and potentially life-threatening reaction to the commonly prescribed antibiotic vancomycin.

Read more


Modulating stress circuits

Feb. 15, 2019—Danny Winder and colleagues have demonstrated how norepinephrine and a stress factor call CRF interact, which may lead to new treatments for stress-related disorders.

Read more


Lindsley named fellow of National Academy of Inventors

Jan. 4, 2019—Craig Lindsley, co-director of the Vanderbilt Center for Neuroscience Drug Discovery, has been named a fellow of the National Academy of Inventors.

Read more


Cytokine-cognition connection

Oct. 4, 2018—Erin Calipari and colleagues have shown that peripheral administration of a neuroprotective cytokine may improve dopamine signaling problems associated with certain psychiatric disorders.

Read more


Immune system emerges as partner in opioid cravings fight

Sep. 5, 2018—There’s promise in specific immune system peptides—amino acid compounds that signal cells how to function. In this case, they may be affecting brain activity and, by extension, drug cravings.

Read more


Scavengers “protect” HDL

Jun. 29, 2018—Lipid molecules that bind to HDL can modify its function — and blocking that modification can protect HDL and potentially lower the risk of atherosclerosis and heart disease.

Read more


Roden’s circulatory diseases research honored

Jun. 21, 2018—Vanderbilt University’s Dan Roden, MD, internationally known for his contributions to understanding how genetic variation affects drug response, has been named a recipient of the 2018 Louis and Artur Lucian Award for Research in Circulatory Diseases by McGill University in Montreal, Canada.

Read more


Upcoming Events

MORE EVENTS »